Trademark Overview
On Tuesday, September 5, 2023, a trademark application was filed for CRISPR THERAPEUTICS with the United States Patent and Trademark Office. The USPTO has given the CRISPR THERAPEUTICS trademark a serial number of 98164704. The federal status of this trademark filing is NEW APPLICATION - ASSIGNED TO EXAMINER as of Wednesday, May 1, 2024. This trademark is owned by CRISPR Therapeutics AG. The CRISPR THERAPEUTICS trademark is filed in the Pharmaceutical Products category with the following description:
Cells for medical or clinical use; pharmaceutical and biopharmaceutical agents for the treatment of cancer, infectious disease, autoimmune disorders, transplant rejections and inflammatory disease; pharmaceutical and biopharmaceutical preparations and substances for the treatment of cancer, infectious disease, autoimmune disorders, transplant rejections and inflammatory disease; pharmaceutical products and preparations, namely, gene transfer, regulation, modulation and delivery pharmaceuticals for the treatment of genetic diseases and disorders
